AROMASIN is indicated for adjuvant cure of postmenopausal women with estrogen-receptor optimistic early breast cancer who've obtained two to a few many years of tamoxifen and they are switched to AROMASIN for completion of a total of five consecutive years of adjuvant hormonal therapy [see Scientific Studies (fourteen.1)].Adjuvant treatment method